Status:
COMPLETED
Effect of Oocyte Vitrification on Fertilization Rate, Embryo Quality and Development
Lead Sponsor:
Main Line Fertility Center
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Fertility
Eligibility:
FEMALE
21-37 years
Phase:
EARLY_PHASE1
Brief Summary
Indications for oocyte (egg) vitrification (fast freezing) include the preservation of reproductive competence of young cancer patients who need chemotherapy, pelvic radiation, or surgical removal of ...
Eligibility Criteria
Inclusion
- healthy women ages 21-37 (inclusive)undergoing IVF in an attempt to achieve pregnancy
- Day 2-4 FSH \< 10 IU/ml, LH \<12 IU/ml, and E2 \<50 pg/ml
- Antimullerian Hormone (AMH) \>1.5
- Between 5 and 20 basal antral follicles on day 2-4 of the menstrual cycle
- BMI \>18 and \<32
Exclusion
- Smokers
- Polycystic Ovarian Syndrome (PCO)
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01422395
Start Date
August 1 2011
End Date
May 1 2013
Last Update
June 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Main Line Fertility Center
Bryn Mawr, Pennsylvania, United States, 19010